FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

412077000: Adrenal hormone agent (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3199501000005112 binyrehormonmiddel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    binyrehormonmiddel Is a Adrenal hormone false Inferred relationship Some
    binyrehormonmiddel Is a Drug allergen false Inferred relationship Some
    binyrehormonmiddel This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Adrenal hormone (disposition) false Inferred relationship Some
    binyrehormonmiddel Is a Hormone false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Triamcinolone 80mg/2mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing precisely fludrocortisone acetate 100 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Flunisolide 25 microgram/actuation nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing prednicarbate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Prednicarbate 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing clocortolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    clocortolonpivalat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing precisely clocortolone pivalate 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    mometasonfuroatmonohydrat 0,05 % vandig næsespray uden duftstof The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    budesonid 64 µg vandig næsespray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    budesonid 200 µg tørpulver cylinderampul og genopfyldeligt inhalationsudstyr The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    clobetasonbutyrat + oxytetracyclin + nystatin creme The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing fluprednidene (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing fluprednidene and miconazole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Fluprednidene acetate 1 mg/g and miconazole nitrate 20 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing budesonide and formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    budesonid 80 µg + formoterol 4,5 µg tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    budesonid 160 µg + formoterol 4,5 µg tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    budesonid 320 µg + formoterol 9 µg tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Amcinonide 1 mg/mL cutaneous lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Fluocinolone acetonide 100 microgram/mL cutaneous oil The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Dermasmoothe/fs The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    budesonid 200 µg inhalator med spacer-anordning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    budesonid 400 µg inhalationspulver kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    budesonid 200 µg inhalationspulver kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    diflorasondiacetat 0,5 mg salve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing precisely diflorasone diacetate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    triamcinolonacetonid 0,055 mg/inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Beclomethasone dipropionate 8.4mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    loteprednoletabonat + tobramycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    methylprednisolonacetat 80 mg/ml injektionsvæske, suspension, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing precisely fluocinonide 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    budesonid 200 µg tørpulver cylinderampul til genopfyldning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing ciclesonide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    ciclesonid 80 µg inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    ciclesonid 160 µg inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    mometasonfuroat 200 µg hættaktiveret tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    fluocinolon 0,59 mg implantat til anvendelse i øje The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Prednisolone 3 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Prednisolone (as prednisolone sodium phosphate) 5 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 50 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 125 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    salmeterol 50 µg + fluticasonpropionat 100 µg indåndingsudløst tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    salmeterol 50 µg + fluticasonpropionat 250 µg indåndingsudløst tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    salmeterol 50 µg + fluticasonpropionat 0500 µg indåndingsudløst tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some
    Product containing fluticasone and salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False binyrehormonmiddel Inferred relationship Some

    Start Previous Page 9 of 9


    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start